Ovarian Cancer Coverage from Every Angle

Recent News

FDA Grants Priority Review to Olaparib/Bevacizumab as Maintenance Therapy for Ovarian Cancer
Proteomic Analysis Identifies ADNP Gene as Mediator of Cell Proliferation in Ovarian Cancer
Protein Targeted in Ovarian Cancer Stem Cells
Are Calreticulin Levels Related to Ovarian Cancer Prognosis?
Identifying a Novel Pathway to Platinum Resistance in Ovarian Cancer
Novel Adenovirus Plus Chemotherapy for Platinum-Resistant Ovarian Cancer
Mirvetuximab Soravtansine Versus Chemotherapy in Platinum-Resistant Ovarian Cancer
NCRI Conference: Early Testing for Levels of CA125 in Diagnosing Ovarian Cancer
Gift of $5M From Leonard A. Lauder to Advance Research in Ovarian Cancer
Does Trametinib Treatment Improve Outcomes in Rare Ovarian Cancer Subtype?
ESMO 2019: Activity of Cediranib Plus Olaparib in Platinum-Resistant Ovarian Cancer
Niraparib Approved by FDA for HRD-Positive Advanced Ovarian Cancer
ESMO 2019: ATR Inhibitor Plus Gemcitabine in High-Grade Serous Ovarian Cancer
ESMO 2019: Olaparib Plus Bevacizumab as Maintenance Therapy for Ovarian Cancer
ESMO 2019: PARP Inhibitor of Benefit in Newly Diagnosed Advanced Ovarian Cancer
ESMO 2019: Adding Veliparib to Front-Line Treatment of High-Grade Serous Carcinoma
Insurance and Mortality in Ovarian and Other Cancers
FAK Signaling and Chemotherapy Resistance in Ovarian Cancer
FDA Grants Accelerated Approval of Pembrolizumab Plus Lenvatinib in Advanced Endometrial Carcinoma
Case Study of Ovarian Mature Teratoma Examines Rare Tumor-to-Tumor Metastasis
Report of Progressive Multifocal Leukoencephalopathy After Platinum-Based Therapy for Ovarian Cancer
Patient-Physician Communication Among Women With Lynch Syndrome
Consequences of Restricting Hospital Choices for Ovarian Cancer Surgery
ALLOCATE Trial: Is Targeted Molecular Profiling Useful in Treating Ovarian Cancer?
Temozolomide Analog Under Study in Treatment of Ovarian Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.